InnovAge Holding Corp. Income Statement
INNV / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
InnovAge Holding Corp. reported $854M in revenue and $30M in net loss for FY2025. Revenue has grown at a 8.5% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $853.7M | $763.9M | $688.1M | $698.6M | $637.8M | $567.2M |
| Gross Profit | $153.6M | $132.1M | $101.3M | $135.4M | - | - |
| SG&A Expense | $122.1M | $111.3M | $115.6M | $101.7M | $132.3M | $58.5M |
| Operating Income | -$29.8M | -$23.2M | -$49.4M | -$4.4M | -$12.3M | $50.9M |
| Interest Expense | - | - | - | $2.5M | $16.8M | $14.6M |
| Income Tax | $1.3M | $1.4M | -$7.2M | $723.0K | $9.8M | $9.9M |
| Net Income | -$30.3M | -$21.3M | -$40.7M | -$6.5M | -$44.0M | $26.3M |
| EPS (Basic) | -$0.16 | -$0.30 | -$0.05 | -$0.36 | $0.20 | $0.20 |
| EPS (Diluted) | -$0.16 | -$0.30 | -$0.05 | -$0.36 | $0.19 | $0.19 |
| Shares Outstanding | 136.1M | 135.6M | 135.5M | 123.6M | 135.2M | 135.2M |
| Gross Margin | 18.0% | 17.3% | 14.7% | 19.4% | - | - |
| Operating Margin | -3.5% | -3.0% | -7.2% | -0.6% | -1.9% | 9.0% |
| Profit Margin | -3.5% | -2.8% | -5.9% | -0.9% | -6.9% | 4.6% |